BRIEF-GlaxoSmithKline seeks U.S. approval for melanoma drug combination
July 09, 2013 at 02:06 AM EDT
LONDON, July 9 (Reuters) - GlaxoSmithKline Plc : * GSK announces U.S. submission for dabrafenib/trametinib combination in
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.